Skip to main content

Advertisement

Log in

Octreotide for Conservative Management of Intractable High Output Post Operative Chylous Fistula: A Case Report

  • Case Report
  • Published:
Journal of Maxillofacial and Oral Surgery Aims and scope Submit manuscript

Abstract

A case of high output post neck dissection chylous fistula is presented, which was successfully managed conservatively with octreotide; a long acting somatostatin analogue. Routine measures had failed, and secondary complications precluded thoracoscopic ligation. We discuss the spectrum of problems associated with chylous fistula and review the rationale behind the use of octreotide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Ramos W, Faintuch J (1986) Nutritional management of thoracic duct fistulas. A comparative study of parenteral versus enteral nutrition. J Parenter Enter Nutr 10:519–521

    Article  CAS  Google Scholar 

  2. Spiro JD, Spiro RH, Strong EW (1990) The management of chyle fistula. Laryngoscope 100:771–774

    Article  CAS  PubMed  Google Scholar 

  3. Kassel RN, Havas TE, Gullane PJ (1987) The use of topical tetracycline in the management of persistent chylous fistulae. J Laryngol Otol 16:174–178

    CAS  Google Scholar 

  4. Kilic D, Sahin E et al (2005) Octreotide for treating chylothorax after cardiac surgery. Tex Heart Inst J 32(3):437–439

    PubMed Central  PubMed  Google Scholar 

  5. al-khayat M, Kenyon GS, Fawcet HC, Powell-Tuck J (1991) Nutritional support in patients with low volume chylous fistula following radical neck dissection. J Laryngol Otol 105:1052–1056

    Article  CAS  PubMed  Google Scholar 

  6. Buck Marcia L (2004) Octreotide for the management of chylothorax in infants and children. Pediatr Pharm 10(10) http://www.medscape.com/viewarticle/494653. Accessed 26 April 2011

  7. Valentine CN, Barresi R, Prinz RA (2002) Somatostatin analog treatment of a cervical thoracic duct fistula. Head Neck 24(8):810–813

    Article  PubMed  Google Scholar 

  8. Nyquist G, Abdulrahman Hagr, Sobol SE, Hier MP, Black MJ (2003) Octreotide in the medical management of chyle fistula. Otolaryngol Head Neck Surg 128(6):910–911

    Article  PubMed  Google Scholar 

  9. Kumar S, Kumar A, Pawar DK (2004) Thoracoscopic management of thoracic duct injury: is there a place for conservatism? J Postgrad Med 50:57–59

    CAS  PubMed  Google Scholar 

  10. Gómez-Caro Andrés A, Marrón Fernández C et al (2004) Octreotide for conservative management of postoperative chylothorax. Arch Bronconeumol 40:473–475

    Article  PubMed  Google Scholar 

  11. Boffa DJ, Sands MJ, Rice TW, Murthy SC, Mason DP, Geisinger MA, Blackstone EH (2008) A critical evaluation of a percutaneous diagnostic, treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg 33(3):435–439

    Article  PubMed  Google Scholar 

  12. Cope C (2004) Management of chylothorax via percutaneous embolization. Curr Opin Pulm Med 10(4):311–314

    Article  PubMed  Google Scholar 

Download references

Competing interests

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sundararaman Prabhu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prabhu, S., Thomas, S. Octreotide for Conservative Management of Intractable High Output Post Operative Chylous Fistula: A Case Report. J. Maxillofac. Oral Surg. 14 (Suppl 1), 21–24 (2015). https://doi.org/10.1007/s12663-011-0269-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12663-011-0269-y

Keywords

Navigation